<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The clinical spectrum of <z:e sem="disease" ids="C0546837,C0014859" disease_type="Neoplastic Process" abbrv="">esophageal cancer</z:e> has changed dramatically over the past couple of decades </plain></SENT>
<SENT sid="1" pm="."><plain>Most notably, a profound rise in esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> and decrease in the incidence of squamous <z:mp ids='MP_0002038'>carcinomas</z:mp> have occurred </plain></SENT>
<SENT sid="2" pm="."><plain>An understanding of the factors that influence survival for patients with localized <z:e sem="disease" ids="C0546837,C0014859" disease_type="Neoplastic Process" abbrv="">esophageal cancer</z:e> has evolved concomitantly with these changes in epidemiology </plain></SENT>
<SENT sid="3" pm="."><plain>Significant advancement in endoscopic and radiographic staging allows for more selective use of treatment modalities </plain></SENT>
<SENT sid="4" pm="."><plain>The treatment of localized <z:e sem="disease" ids="C0546837,C0014859" disease_type="Neoplastic Process" abbrv="">esophageal cancer</z:e> mandates a multidisciplinary approach, with treatment tailored to disease extent, location, histology, and an accurate assessment of pretreatment staging </plain></SENT>
<SENT sid="5" pm="."><plain>Despite these improvements in the staging and use of multimodality therapy, only modest improvements in patient survival have been observed </plain></SENT>
<SENT sid="6" pm="."><plain>This article summarizes these modern approaches to <z:e sem="disease" ids="C0796563,C1334407" disease_type="Neoplastic Process" abbrv="">localized cancer</z:e> of the esophagus </plain></SENT>
</text></document>